Steven D Shnyder

Steven D Shnyder

University of Bradford

H-index: 35

Europe-United Kingdom

About Steven D Shnyder

Steven D Shnyder, With an exceptional h-index of 35 and a recent h-index of 23 (since 2020), a distinguished researcher at University of Bradford, specializes in the field of Preclinical Cancer Pharmacology, Cancer Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

A Proteomic Investigation to Discover Candidate Proteins Involved in Novel Mechanisms of 5-Fluorouracil Resistance in Colorectal Cancer

Synthesis and Biological Evaluation of Cyclobutane-Based β3 Integrin Antagonists: A Novel Approach to Targeting Integrins for Cancer Therapy

Investigation to explore how duocarmycin prodrugs bioactivated by cytochrome P450 enzymes can be used in combination therapy to treat breast cancer cells

Hexapeptides from mammalian inhibitory hormone hunt activate and inactivate nematode reproduction

Animal Models in Monoclonal Immunoglobulin-Related Diseases

Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation

Controlled bioactive delivery using degradable electroactive polymers

Cellular uptake and metabolism of MT1-MMP-activated taxane prodrugs

Steven D Shnyder Information

University

Position

Senior Lecturer in Cancer Biology UK

Citations(all)

3710

Citations(since 2020)

1290

Cited By

3001

hIndex(all)

35

hIndex(since 2020)

23

i10Index(all)

62

i10Index(since 2020)

44

Email

University Profile Page

Google Scholar

Steven D Shnyder Skills & Research Interests

Preclinical Cancer Pharmacology

Cancer Biology

Top articles of Steven D Shnyder

A Proteomic Investigation to Discover Candidate Proteins Involved in Novel Mechanisms of 5-Fluorouracil Resistance in Colorectal Cancer

Cells

2024/2/14

Steven D Shnyder
Steven D Shnyder

H-Index: 23

Synthesis and Biological Evaluation of Cyclobutane-Based β3 Integrin Antagonists: A Novel Approach to Targeting Integrins for Cancer Therapy

Cancers

2023/8/8

Investigation to explore how duocarmycin prodrugs bioactivated by cytochrome P450 enzymes can be used in combination therapy to treat breast cancer cells

Cancer Research

2023/4/4

Steven D Shnyder
Steven D Shnyder

H-Index: 23

Hexapeptides from mammalian inhibitory hormone hunt activate and inactivate nematode reproduction

Plos one

2022/12/1

Animal Models in Monoclonal Immunoglobulin-Related Diseases

2022/11/15

Steven D Shnyder
Steven D Shnyder

H-Index: 23

Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation

ChemBioChem

2022/9/16

Steven D Shnyder
Steven D Shnyder

H-Index: 23

Controlled bioactive delivery using degradable electroactive polymers

Biomacromolecules

2022/6/24

David Cheneler
David Cheneler

H-Index: 7

Steven D Shnyder
Steven D Shnyder

H-Index: 23

Cellular uptake and metabolism of MT1-MMP-activated taxane prodrugs

Cancer Research

2022/6/15

Semi-Synthetic Analogues of Cryptolepine as a Potential Source of Sustainable Drugs for the Treatment of Malaria, Human African Trypanosomiasis, and Cancer. Front. Pharmacol …

Frontiers in Pharmacology

2022/4/26

The role of MT1-MMP in the progression and metastasis of osteosarcoma

2022

Anticancer water-soluble organoruthenium complexes: synthesis and preclinical evaluation

2022

Hexapeptides from a mammalian inhibitory hormone activate and inactivate nematode reproduction

bioRxiv

2021/9/30

Cytochrome P450 isoforms 1A1, 1B1 AND 2W1 as targets for therapeutic intervention in head and neck cancer

Scientific Reports

2021/9/23

Methods of assessment of polysialyltransferase inhibitors for treatment of tumor cell dissemination

Cancer Research

2021/7/1

Steven D Shnyder
Steven D Shnyder

H-Index: 23

Laurence H Patterson
Laurence H Patterson

H-Index: 20

Synthesis and evaluation of FPR1 inhibitors as a novel treatment for cancers

Cancer Research

2021/7/1

Probing cytochrome P450 (CYP) bioactivation with chloromethylindoline bioprecursors derived from the duocarmycin family of compounds

Bioorganic & Medicinal Chemistry

2021/6/15

An assay for quantitative analysis of polysialic acid expression in cancer cells

Carbohydrate Polymers

2021/5/1

Steven D Shnyder
Steven D Shnyder

H-Index: 23

Laurence H Patterson
Laurence H Patterson

H-Index: 20

Recent advances in the chemistry and pharmacology of Cryptolepine

2021

Steven D Shnyder
Steven D Shnyder

H-Index: 23

Application of small molecule FPR1 antagonists in the treatment of cancers

Scientific reports

2020/10/14

Optimizing the combination of the CDK4/6 inhibitor palbociclib and paclitaxel using cell cycle analysis

Cancer Research

2020/8/15

Steven D Shnyder
Steven D Shnyder

H-Index: 23

See List of Professors in Steven D Shnyder University(University of Bradford)